PLSE - Pulse Biosciences, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development17,2539,6465,5062,181
Selling General and Administrative20,04515,5033,4151,621
Non Recurring----
Others----
Total Operating Expenses37,96325,8149,5864,468
Operating Income or Loss-37,963-25,814-9,586-4,468
Income from Continuing Operations
Total Other Income/Expenses Net41824768-
Earnings Before Interest and Taxes-37,963-25,814-9,586-4,468
Interest Expense----
Income Before Tax-37,545-25,567-9,518-4,468
Income Tax Expense----1,657
Minority Interest----
Net Income From Continuing Ops-37,545-25,567-9,518-2,811
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-37,545-25,567-9,518-2,811
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-37,545-25,567-9,518-2,811